Roche's novel 5-ht6 receptor ligands are broadly useful in treating CNS and neurologic disorders Aug. 12, 1999
PRAISE study will evaluate Merck drug's ability to prevent AD in patients with mild memory loss Aug. 11, 1999
Ropinirole is associated with a 15% lower risk of dyskinesia than L-dopa in early-stage PD patients Aug. 10, 1999
RSS